Bao F - Search Results

1

Epidemiological characterization of respiratory tract infections caused by Mycoplasma pneumoniae during epidemic and post-epidemic periods in North China, from 2011 to 2016.

Qu J, Yang C, Bao F, Chen S, Gu L, Cao B. Qu J, et al. Among authors: bao f. BMC Infect Dis. 2018 Jul 17;18(1):335. doi: 10.1186/s12879-018-3250-2. BMC Infect Dis. 2018. PMID: 30016939 Free PMC article.

2

[The clinical characteristics, treatment and outcome of macrolide-resistant Mycoplasma pneumoniae pneumonia in children].

Bao F, Qu JX, Liu ZJ, Qin XG, Cao B. Bao F, et al. Zhonghua Jie He He Hu Xi Za Zhi. 2013 Oct;36(10):756-61. Zhonghua Jie He He Hu Xi Za Zhi. 2013. PMID: 24433804 Chinese.

3

Molecular characterization and analysis of Mycoplasma pneumoniae among patients of all ages with community-acquired pneumonia during an epidemic in China.

Qu J, Chen S, Bao F, Gu L, Cao B. Qu J, et al. Among authors: bao f. Int J Infect Dis. 2019 Jun;83:26-31. doi: 10.1016/j.ijid.2019.03.028. Epub 2019 Mar 26. Int J Infect Dis. 2019. PMID: 30926541 Free article.

4

[Clinical Characteristics and Prognosis of 84 Elderly Patients with Acute Myeloid Leukemia].

Wan W, Wang J, Dong F, Zhao W, Tian L, Hu K, Li QH, Yang P, Bao F, Jing HM. Wan W, et al. Among authors: bao f. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2019 Jun;27(3):692-701. doi: 10.19746/j.cnki.issn.1009-2137.2019.03.009. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2019. PMID: 31204918 Chinese.

5

[Analysis of the correlation between lymphocyte subsets and severity of corona virus disease 19].

Bao F, Shi WL, Hu J, Zhang D, Gao DH, Xia YX, Jing HM, Ke XY, Ge QG, Shen N. Bao F, et al. Beijing Da Xue Xue Bao Yi Xue Ban. 2020 Dec 18;52(6):1075-1081. doi: 10.19723/j.issn.1671-167X.2020.06.014. Beijing Da Xue Xue Bao Yi Xue Ban. 2020. PMID: 33331316 Free PMC article. Chinese.

6

Model-based Voriconazole Dose Optimization in Chinese Adult Patients With Hematologic Malignancies.

Liu Y, Qiu T, Liu Y, Wang J, Hu K, Bao F, Zhang C. Liu Y, et al. Among authors: bao f. Clin Ther. 2019 Jun;41(6):1151-1163. doi: 10.1016/j.clinthera.2019.04.027. Epub 2019 May 10. Clin Ther. 2019. PMID: 31079860

7

[Efficacy of anti-CD19 CAR-T cell therapy in 10 refractory recurrent B cell malignancies].

Bao F, Hu K, Wan W, Tian L, Jing HM. Bao F, et al. Zhonghua Xue Ye Xue Za Zhi. 2018 Jun 14;39(6):454-459. doi: 10.3760/cma.j.issn.0253-2727.2018.06.003. Zhonghua Xue Ye Xue Za Zhi. 2018. PMID: 30032559 Free PMC article. Chinese.

8

[Application of CD19-CAR T Cells in Refractory Relapsed Acute B Lymphocyte Leukemia].

Bao F, Hu K, Wan W, Tian L, Jing HM. Bao F, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018 Dec;26(6):1604-1609. doi: 10.7534/j.issn.1009-2137.2018.06.004. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018. PMID: 30501691 Chinese.

9

[Relationship of the Changes of Peripheral Blood Immuno-Cell Subsets with the Prognosis of B Cell Lymphoma Patients].

Zhen JF, Bao F, Zhu MX, Wang J, An R, Pang M, Jing HM. Zhen JF, et al. Among authors: bao f. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018 Dec;26(6):1657-1662. doi: 10.7534/j.issn.1009-2137.2018.06.013. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018. PMID: 30501700 Chinese.

10

Autologous CD19-directed chimeric antigen receptor-T cell is an effective and safe treatment to refractory or relapsed diffuse large B-cell lymphoma.

Bao F, Wan W, He T, Qi F, Liu G, Hu K, Lu XA, Yang P, Dong F, Wang J, Jing H. Bao F, et al. Cancer Gene Ther. 2019 Jul;26(7-8):248-255. doi: 10.1038/s41417-018-0073-7. Epub 2019 Jan 9. Cancer Gene Ther. 2019. PMID: 30622321 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

877 results

Search Page

Filters